IGFBPs have been implicated in the development and pathogenesis of obesity and its related comorbidities like diabetes, metabolic syndrome and cardiovascular diseases (CVDs) through IGF-dependent as well as IGF-independent roles (12, 13). Here, IGF1 is linked to obesity disorder.